Your Reliable Partner in Patient Care The company started its operations as a subsidiary of Pfizer Limited in 1972.
(488)
For the next two decades it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s the focus of Pfizer had shifted from formulations to research. In accordance with this transformation, Pfizer divested its interests in many countries, including Bangladesh. In 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited. In a gesture of corporate charity, Pfizer donated 51% of its shares to SAJIDA Foundation. SAJIDA’s microfinance and micro-insurance programs support over 1 lac members and their families with a cumulative loan disbursement totaling to about BDT 575 Crores. SAJIDA’s health program covers over 10 lac beneficiaries by delivering services through 2 hospitals with 70 beds each, a panel doctors in SAJIDA’s micro finance branches as well as mobile health teams. The SAJIDA Foundation holds the majority ownership in Renata Limited - it grows with the growth of Renata Limited. To learn more please visit the foundation’s website: www.sajidafoundation.org
Renata Limited contributes about BDT 150 Crores annually to the National Exchequer. Renata's Global Alliances are:
UNICEF (Oral Re-hydration Salts)
Novartis Vaccines (Rabipur, Vaxem HiB, and Agrippal)
BASF, Germany (Animal Nutrition Products)
InterVax, Canada (Meningococcal Vaccine)
Evans Vanodine, UK (Disinfectant)
Zinpro, USA (Metal Amino Acid Complexes)
Biomin Laboratories, Singapore (Mycotoxin Binders and Nutraceuticals)
Bomac Laboratories, New Zealand (Veterinary Products)
Renata Limited has International Presence in:
UK, Hong Kong, Philippines, Sri Lanka, Vietnam, Belize, Myanmar, Nepal, Cambodia, Kenya, Jordan, Guyana, Thailand, Afghanistan and Malaysia.
27/09/2025
UNESCO, University of Dhaka and Renata organise global forum on cancer genetics.
An international scientific programme on "Human Genome, Cancer and Cancer Genetic Counselling" was held on Saturday (27 September) at Dhaka Sheraton, Banani, jointly organised by UNESCO, the University of Dhaka, and Renata PLC. The event brought together leading global experts in cancer research and...
25/09/2025
Renata PLC proudly sponsored and took part in the Best of ASCO & MOSB Congress 2025, held on 18–19 September at Pan Pacific Sonargaon, Dhaka.
The two-day event brought together prominent oncologists, researchers, and healthcare professionals from across the globe to exchange insights on the latest developments in cancer research and treatment. This year, Renata facilitated the participation of esteemed global experts, including Prof. Nicholas Anthony Othieno-Abinya from Kenya and Prof. Dr. Mark Athumani Sandarya Mseti from Tanzania, who shared their valuable perspectives on evolving cancer care practices.
Adding further depth to our presence, Mr. Seth Oketch and Mr. Francis Usaki represented Renata’s Global Operations team from Africa. During the congress, Mr. Tanbir Sajib, Chief Marketing Officer of Renata PLC, engaged with key opinion leaders and reiterated our ongoing commitment to improving access to high-quality bioequivalent anticancer medicines and advancing cancer care in Bangladesh.
25/09/2025
Every day, pharmacists across the globe help meet critical health needs. World Pharmacists Day is the opportunity to celebrate this profession and it's remarkable contributions to improve health outcomes.
"Think Health, Think Pharmacist"
24/09/2025
Renata PLC was honoured as the only company from the pharmaceutical industry, to receive the “eReturn Champion Certificate” for the fiscal year 2024-2025. The award was presented by the National Board of Revenue (NBR) under the Bangladesh Single Window (BSW) Project. A total of five companies from various industries received this award in recognition.
Mr. Mustafa Alim Aolad, Chief Financial Officer, received the award on behalf of Renata PLC on 19 September, 2025.
24/09/2025
NBR awards ‘e-Return Champion Certificate’ to Renata PLC along with four other companies.
Recipients of the awards include BAT Bangladesh, Sonali Bank, Brac Bank, Renata Pharmaceuticals, and Bureau Bangladesh
23/09/2025
In this episode of "Turning the Tides", titled “Global Frontiers”, we explore the world beyond borders with voices from Renata’s International Business Division. Host Nafisa Fairuz sits down with Shams-Ud-Dowla, Ashima Aziz, and Md. Rezwanul Kabir Niloy, to uncover the strategies, challenges, and aspirations that shape Renata’s global footprint. It’s not just about expansion; it’s about vision, resilience, and redefining possibilities.
22/09/2025
Renata PLC consistently fosters industry–academia collaboration. Recently, Renata partnered with BRAC University Pharma Society in an event named PharmaBuzz 8.0 in celebration of World Pharmacists Day and as part of Renata On Campus Program.
The event showcased a series of engaging segments, Poster Presentation on Drug Formulation and Dosage Forms, a spirited Quiz Competition and Pharma Society Club Orientation. Mr. Md. Amir Abdullah, Head of Marketing, Oncology & Hematology Portfolio, Renata PLC, graced the event as the guest of honor, where he delivered inspiring words of encouragement and support to the aspiring pharmacists, motivating them to pursue excellence in their professional journey. He was accompanied by other members of Marketing Pharma Division and Human Resources Division.
By sponsoring this celebration of innovation, knowledge and the spirit of pharmacy, Renata PLC strengthened its collaboration with BRAC University and continues to inspire the next generation of pharmaceutical professionals.
18/09/2025
While the innovator and other generics have Rivaroxaban in tablet form, we are the only company to deliver the product in capsules to Australia.
Renata PLC has shipped its rivaroxaban capsules to Australia, marking the first time the widely used anticoagulant is available in capsule form in the country.
14/09/2025
Renata PLC proudly marks a new milestone with the launch of its first Canadian product — Desogestrel/Ethinylestradiol (0.15mg/0.03mg) tablets, locally branded as Desolon.
10/09/2025
We are now in Canada.
Renata PLC has launched its first Canadian product: Desogestrel/Ethinylestradiol (0.15mg/0.03mg) tablets. The oral contraceptive combines Desogestrel, a progestin, with Ethinylestradiol, an oestrogen, in a fixed-dose formulation.
10/09/2025
Even in the darkest moments, hope can rise like the sun. Your life matters.
World Su***de Prevention Day
September 10, 2025
08/09/2025
Sustainability is not an option, it is our responsibility.
Be the first to know and let us send you an email when Renata PLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Whenever there is a talk regarding the big market players of the Pharmaceutical industry in Bangladesh, Renata Limited is certain to come in the mind of consumers with their exceptional pharmaceutical products like Maxpro, Fedadin, Algin, yet more to count. It is the 4th largest pharmaceutical company in Bangladesh and the market leader in the Animal health product. Renata Limited besides serving in Pharmaceuticals, has stretched its branches in 3 more fields, naming- Purnava Limited (Non-medicated healthcare), Renata Agro Industries Limited (Poultry Operations), Renata Oncology Limited (Manufacturing of oncological medicines).
Renata Limited, just like the meaning of its name got “reborn” in 1993, after its long journey as Pfizer(Bangladesh) Limited since 1972. After years of hard work, now Renata Limited has earned the place as a $1 billion company and succeeding in great momentum than ever.
In a gesture of corporate charity, Pfizer donated 51% of its shares to SAJIDA Foundation. SAJIDA’s microfinance and micro-insurance programs support over 1 lac members and their families with a cumulative loan disbursement totaling to about BDT 575 Crores. SAJIDA’s health program covers over 10 lac beneficiaries by delivering services through 2 hospitals with 70 beds each, a panel doctors in SAJIDA’s micro finance branches as well as mobile health teams. The SAJIDA Foundation holds the majority ownership in Renata Limited - it grows with the growth of Renata Limited. To learn more please visit the foundation’s website: www.sajidafoundation.org
Renata Limited contributes about BDT 150 Crores annually to the National Exchequer. Renata's Global Alliances are: UNICEF (Oral Re-hydration Salts) Novartis Vaccines (Rabipur, Vaxem HiB, and Agrippal) BASF, Germany (Animal Nutrition Products) InterVax, Canada (Meningococcal Vaccine) Evans Vanodine, UK (Disinfectant) Zinpro, USA (Metal Amino Acid Complexes) Biomin Laboratories, Singapore (Mycotoxin Binders and Nutraceuticals) Bomac Laboratories, New Zealand (Veterinary Products).
Renata Limited has International Presence in: UK, Hong Kong, Philippines, Sri Lanka, Vietnam, Belize, Myanmar, Nepal, Cambodia, Kenya, Jordan, Guyana, Thailand, Afghanistan and Malaysia.
Amid the heart of busiest metropolitan Dhaka, where work-life balance is rare to find, Renata Limited’s corporate headquarter has a 3-acre wi-fi enabled woodland, which is filled with trees, medical plants and resting arrangements with gym facility for its employees to take a walk in the middle of work break, exploring new ideas and have a breath of fresh air, an overall indulgence for both the body and mind. The Renata family is also very festive at heart. Renata Family celebrates many festivals together with warm heart, by arranging eventful programs and making the team bond stronger than ever.
It is more tough to maintain the success than to achieve it, and Renata Limited with its dynamic hard-working team believes in surpassing their previous achievement with better offering and become stronger version of itself with passing time.